
Applied DNA and Takis Report Positive Preclinical Results from LineaDNA™ Vaccine Candidates for COVID-19
July 17th, 2020
Applied DNA and Takis Report Positive Preclinical Results from LineaDNA™ Vaccine Candidates for COVID-19
July 17th, 2020
Applied DNA Appoints New Head of Investor Relations and Corporate Communications
July 15th, 2020
Applied DNA Forms Clinical Testing Subsidiary to Maximize Utility of FDA EUA-Approved Linea™ COVID-19 Assay Kit and Expands Utility with Successful EUA Amendment
July 9th, 2020
Applied DNA Sciences Set to Join Russell Microcap Index
June 26th, 2020
Applied DNA Secures Grant from National Grid Partnered with the New York State MEP to Support Manufacture of COVID-19 Diagnostic Kits and Vaccine Candidates
June 9th, 2020
APDN Provides Update on Linear-DNA COVID-19 Vaccine Candidates
June 8th, 2020
Applied DNA to Participate in Maxim Group’s COVID-19 Virtual Conference Series on May 27
May 21st, 2020
Applied DNA Reports 2020 Fiscal Second Quarter Financial Results
May 14th, 2020
Applied DNA Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit
May 14th, 2020